Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=26099019&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY102116(A)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP59171069Aexternal-prioritypatent/JPS6150978A/en
Application filed by Takeda Pharmaceuticals CofiledCriticalTakeda Pharmaceuticals Co
Publication of MY102116ApublicationCriticalpatent/MY102116A/en
THE COMPOUND OF THE FORMULA WHEREIN R1 IS HYDROGEN, METHOXY OR TRIFLUOROMETHYL, R2 AND R3 ARE INDEPENDENTLY HYDROGEN OR METHYL, R4 IS A C2-5 FLUORINATED ALKYL AND N DENOTES 0 OR 1, OR A PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF IS NOVEL, AND USEFUL FOR PROPHYLAXIS AND THERAPY OF DIGESTIVE ULCERS (E.G. GASTRIC ULCER, DUODENAL ULCER) AND GASTRITIS.
MYPI87002685A1984-08-161987-09-30Pyridine derivatives and their production
MY102116A
(en)